跳至主要内容
临床试验/NCT00529490
NCT00529490已完成3 期

The Efficacy and Safety of Hypertonic Lactate Solution as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG (Coronary Artery Bypass Grafting) Patients

Innogene Kalbiotech Pte. Ltd1 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2002年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
230
试验地点
1
主要终点
hemodynamic stability

研究概览

简要总结

Prospective, randomized, open-label study to assess the efficacy and safety of hypertonic lactate solution, compared to Ringer's Lactate as fluid resuscitation to maintain hemodynamic stability in post-coronary artery bypass grafting(CABG) patients. Patients who were eligible received either hypertonic lactate solution or Ringer's Lactate post-CABG in the ICU when fluid resuscitation was needed.

详细描述

Prospective, randomized, open-label study to assess the efficacy and safety of hypertonic lactate solution, compared to Ringer's Lactate as fluid resuscitation to maintain hemodynamic stability in post-coronary artery bypass grafting(CABG) patients. Patients who were eligible received either hypertonic lactate solution or Ringer's Lactate post-CABG observed in the first 12 hours in the ICU when fluid resuscitation was needed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have given their written informed consent.
  • Male or female, aged 18-75 years.
  • Post-operative CABG on pump or off pump in ICU.
  • Patients who need fluid resuscitation.

排除标准

  • Combined operations.
  • Need for intra aortic balloon pump (IABP).
  • Patients with severe arrhythmia (VT, AF rapid response, heart block).
  • Severe hemodynamic imbalance.
  • Severe bleeding and/or re-operation.
  • Liver dysfunction(SGOT and SGPT 2x normal).
  • Renal failure (Creatinine >2 mg%).

研究组 & 干预措施

HL

Experimental

Hypertonic lactate group

干预措施: Hypertonic lactate (Drug)

RL

Active Comparator

Ringer's lactate

干预措施: Ringer's lactate (Drug)

结局指标

主要结局

hemodynamic stability

时间窗: 12 hours post-CABG surgery

次要结局

  • Safety of hypertonic sodium lactate for maintaining the hemodynamic stability(12 hours post-CABG surgery)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验